SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

Clinical trial NCT00991250 · UNKNOWN

Trial details

NCT number: NCT00991250
Sponsor: SentoClone AB
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2009-10-01
Primary completion: 2011-09-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.